Essex Investment Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.16M | Sell |
123,691
-892
| -0.7% | -$8.39K | 0.21% | 136 |
|
|
2025
Q1 | $675K | Sell |
124,583
-834
| -0.7% | -$4.52K | 0.14% | 153 |
|
|
2024
Q4 | $934K | Sell |
125,417
-16,727
| -12% | -$125K | 0.17% | 147 |
|
|
2024
Q3 | $1.14M | Buy |
142,144
+99,606
| +234% | +$796K | 0.2% | 141 |
|
|
2024
Q2 | $370K | Sell |
42,538
-107,281
| -72% | -$933K | 0.07% | 172 |
|
|
2024
Q1 | $3.1M | Buy |
149,819
+2,278
| +2% | +$47.1K | 0.61% | 57 |
|
|
2023
Q4 | $3.41M | Sell |
147,541
-59,619
| -29% | -$1.38M | 0.67% | 40 |
|
|
2023
Q3 | $1.66M | Sell |
207,160
-2,789
| -1% | -$22.3K | 0.27% | 129 |
|
|
2023
Q2 | $1.83M | Sell |
209,949
-25,827
| -11% | -$225K | 0.26% | 135 |
|
|
2023
Q1 | $693K | Buy |
235,776
+33,966
| +17% | +$99.9K | 0.1% | 237 |
|
|
2022
Q4 | $706K | Sell |
201,810
-140,164
| -41% | -$490K | 0.11% | 227 |
|
|
2022
Q3 | $2.71M | Buy |
341,974
+62,124
| +22% | +$491K | 0.43% | 73 |
|
|
2022
Q2 | $2.2M | Buy |
279,850
+3,259
| +1% | +$25.6K | 0.36% | 82 |
|
|
2022
Q1 | $3.36M | Buy |
276,591
+52,362
| +23% | +$636K | 0.42% | 66 |
|
|
2021
Q4 | $2.75M | Buy |
224,229
+51,702
| +30% | +$633K | 0.31% | 97 |
|
|
2021
Q3 | $1.8M | Buy |
+172,527
| New | +$1.8M | 0.22% | 160 |
|
|
2020
Q2 | – | Sell |
-63,770
| Closed | -$650K | – | 430 |
|
|
2020
Q1 | $650K | Sell |
63,770
-18,661
| -23% | -$190K | 0.13% | 202 |
|
|
2019
Q4 | $1.28M | Buy |
82,431
+3,866
| +5% | +$59.9K | 0.16% | 205 |
|
|
2019
Q3 | $1.42M | Sell |
78,565
-8,945
| -10% | -$162K | 0.21% | 161 |
|
|
2019
Q2 | $1.44M | Buy |
87,510
+32,535
| +59% | +$534K | 0.2% | 175 |
|
|
2019
Q1 | $984K | Sell |
54,975
-1,839
| -3% | -$32.9K | 0.15% | 206 |
|
|
2018
Q4 | $1.07M | Buy |
56,814
+43,363
| +322% | +$820K | 0.17% | 183 |
|
|
2018
Q3 | $480K | Buy |
13,451
+5,298
| +65% | +$189K | 0.06% | 299 |
|
|
2018
Q2 | $170K | Sell |
8,153
-6,429
| -44% | -$134K | 0.02% | 385 |
|
|
2018
Q1 | $178K | Sell |
14,582
-1,479
| -9% | -$18.1K | 0.02% | 353 |
|
|
2017
Q4 | $173K | Buy |
+16,061
| New | +$173K | 0.02% | 347 |
|